A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma

NCT04268498 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

310

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Bortezomib
DRUG: Dexamethasone
DRUG: Lenalidomide
DRUG: Acetaminophen
DRUG: Diphenhydramine
DRUG: Montelukast
DRUG: Carfilzomib
DRUG: Daratumumab
BIOLOGICAL: Autologous Stem Cell Transplant (ASCT)

Sponsor

University of Miami

Collaborators

[object Object]
[object Object]